# Sunitinib

## Sutent 12.5mg

##### 臨採

| TAH Drug Code      | [OSUT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSUT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 1. Gastrointestinal Stromal Tumors (GIST) Indicated for the treatment of gastrointestinal stromal tumors (GIST) that progress during imatinib mesylate therapy or in patients who cannot tolerate imatinib mesylate. 2. Advanced Renal Cell Carcinoma (RCC) Indicated for the treatment of advanced or metastatic renal cell carcinoma (RCC). 3. Pancreatic Neuroendocrine Tumors (pNET) Indicated for the treatment of progressive, unresectable, or metastatic well-differentiated pancreatic neuroendocrine tumors in adult patients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | [Gastrointestinal Stromal Tumor (GIST) and Advanced Renal Cell Carcinoma (RCC)] 50 mg orally with or without food once daily, on a schedule of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2). [Pancreatic neuroendocrine tumors (pNET)] 37.5 mg orally with or without food once daily continuously without a scheduled off-treatment period. [Adjuvant Treatment of RCC] 50 mg orally with or without food once daily, on a schedule of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2), for nine 6-week cycles.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Pregnancy. Women of childbearing potential should avoid becoming pregnant while receiving treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Fatigue, asthenia, diarrhea, nausea, mucositis/stomatitis, vomiting, dyspensia, abdominal pain, constipation, hypertension, rash, hand-foot syndrome, skin discoloration, altered taste, anorexia & bleeding. Potentially serious adverse reactions of LV dysfunction, QT interval prolongation, hemorrhage, hypertension & adrenal dysfunction. Dermatologic: Discoloration of skin, Yellow (GIST, 30%; MRCC, 19% ), Dry skin (MRCC, 18% ), Rash (GIST, 14%; MRCC, 27% ) Endocrine metabolic: Hypothyroidism (GIST, 4% to 36%; MRCC, 3% ) Gastrointestinal: Abdominal pain (MRCC, 22% ), Constipation (GIST, 20%; MRCC, 16% ), Diarrhea (GIST, 40%; MRCC, 58% ), Increased serum lipase level (GIST, 25%; MRCC, 52% ), Indigestion (MRCC, 28% ), Inflammatory disease of mucous membrane (GIST, 29%; MRCC, 43% ), Loss of appetite (GIST, 33%; MRCC, 38% ), Nausea (MRCC, 49% ), Pain of oral cavity structure (GIST, 6%; MRCC, 10% ), Taste sense altered (GIST, 21%; MRCC, 44% ), Vomiting (MRCC, 28% ) Hematologic: Anemia (GIST, 26%; MRCC, 71% ), Bleeding (GIST, 18%; MRCC, 30% ), Leukopenia (MRCC, 78% ), Lymphocytopenia (GIST, 38%; MRCC, 59% ), Neutropenic disorder (GIST, 53%; MRCC, 72% ) Hepatic: Liver function tests abnormal (GIST, 10% to 39%; MRCC, 13% to 56% ) Neurologic: Asthenia (GIST, 22%; MRCC, 21% ) Renal: Increased uric acid level (MRCC, 41% ) |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sunitinib-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

